AZD1283
AZD1283 is a potent P2Y12 receptor antagonist with a binding IC50 of 11 nM and a GTPγS IC50 of 25 nM. AZD1283 has excellent antiplatelet aggregation potency. AZD1283 can be used to research thromboembolic disorders[1][2].
Product Specifications
CAS Number
919351-41-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/AZD1283.html
Purity
99.33
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C(C(OCC)=O)C=C(C#N)C(N2CCC(C(NS(=O)(CC3=CC=CC=C3)=O)=O)CC2)=N1
Molecular Formula
C23H26N4O5S
Molecular Weight
470.54
Precautions
H302, H315, H319, H335
References & Citations
[1]Bach P, et al. Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283. J Med Chem. 2013 Sep 12;56 (17) :7015-24.|[2]Kong D, et al. Optimization of P2Y12 Antagonist Ethyl 6- (4- ((Benzylsulfonyl) carbamoyl) piperidin-1-yl) -5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties. J Med Chem. 2019 Mar 28;62 (6) :3088-3106.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P2Y12 Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1378407 1.0 µg DNA
MYO1F sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
bsm-52566R-Cy5-TR 20 µL
Caspase-9 Recombinant Antibody, Cy5 Conjugated
Sign In for Pricing
View Details